BackGSK Plc Overview
GSK Plc - ADR

GSK Plc Target Price

Where could GSK trade next? Consensus target price: $60.

Get informed when a big investor buys or sells

+ Follow

Share Price

$49.65

Average Target Price

$60.0020.8% upside

1 analysts in the last 4 months

High: $60 | Low: $60

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-15Berenberg BankKerry Holford$6020.8% upsideOpen
2025-10-30CFRAWan Nurhayati$536.7% upsideOpen
2025-04-15BNP ParibasPeter Verdult$35.2529% downsideOpen
2024-07-02JefferiesPeter Welford$536.7% upsideOpen
2024-04-11GuggenheimVamil Divan$3627.5% downsideOpen
2024-04-11Morgan StanleyMark Purcell$8571.2% upsideOpen

GSK Plc (GSK) FAQ

As of the most recent data, GSK shows a target price of $60. Scroll down for historical charts and peer comparison views.

If GSK Plc moved to the average analyst target of $60, shares would be roughly 20.8% higher than $49.65. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of GSK Plc's earnings trajectory.

Besides this target price page, Stockcircle has GSK Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $60) with ownership activity and broader fundamentals.

GSK Plc's target price is $60; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.